Literature DB >> 35340503

Pseudomyxoma Peritonei: A Case Report of a 62-Year-Old Female With Unexplained Abdominal Enlargement and Appendiceal Origin.

Ahmed Mohfouz1, Manar Hamed2, Anshul Patel1, Shams Tasnim1, Princy Shah1.   

Abstract

Pseudomyxoma peritonei (PMP) is any mucin-producing tumor in the abdomen. If left untreated, it can compress vital abdominal organs. We describe a misleading presentation of disseminated peritoneal adenomucinosis (DPAM) of appendiceal origin. Treatment strategies for PMP vary from watchful waiting to cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) or early postoperative intraperitoneal chemotherapy (EPIC). The rarity of PMP has precluded any randomized studies, and few institutions see sufficient cases to report a series. The purpose of this case report is to contribute to reaching a common consensus on the guidelines of pseudomyxoma peritonei. Recent studies support that cytoreduction followed by HIPEC improves survival in patients with peritoneal carcinomatosis of colorectal origin. Our case report introduced a patient with low-grade appendiceal mucinous neoplasm with visceral peritoneal penetration who underwent surgical debulking with promising results that supports the practice. Our patient has also responded well to adjuvant systemic chemotherapy without hyperthermic intraperitoneal chemotherapy.
Copyright © 2022, Mohfouz et al.

Entities:  

Keywords:  adenomucinosis; appendiceal; chemotherapy response; hipec; omental cake; pseudomyxoma peritonei

Year:  2022        PMID: 35340503      PMCID: PMC8930471          DOI: 10.7759/cureus.22255

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  7 in total

Review 1.  [Pseudomyxoma peritonei. A review].

Authors:  D Elias; J C Sabourin
Journal:  J Chir (Paris)       Date:  1999-12

2.  Pseudomyxoma peritonei: A rose by any other name...

Authors:  Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2006-11       Impact factor: 6.394

Review 3.  Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality.

Authors:  Terence C Chua; Tristan D Yan; Akshat Saxena; David L Morris
Journal:  Ann Surg       Date:  2009-06       Impact factor: 12.969

Review 4.  The histopathological classification, diagnosis and differential diagnosis of mucinous appendiceal neoplasms, appendiceal adenocarcinomas and pseudomyxoma peritonei.

Authors:  Norman J Carr; Frederic Bibeau; Robert F Bradley; Peggy Dartigues; Roger M Feakins; Kim R Geisinger; Xianyong Gui; Sylvie Isaac; Massimo Milione; Joseph Misdraji; Reetesh K Pai; Manuel Rodriguez-Justo; Leslie H Sobin; Marie-Louise F van Velthuysen; Rhonda K Yantiss
Journal:  Histopathology       Date:  2017-09-19       Impact factor: 5.087

5.  Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.

Authors:  Vic J Verwaal; Serge van Ruth; Eeclo de Bree; Gooike W van Sloothen; Harm van Tinteren; Henk Boot; Frans A N Zoetmulder
Journal:  J Clin Oncol       Date:  2003-10-15       Impact factor: 44.544

6.  Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms.

Authors:  Tristan D Yan; Lana Bijelic; Paul H Sugarbaker
Journal:  Ann Surg Oncol       Date:  2007-06-01       Impact factor: 5.344

7.  Aggressive pseudomyxoma peritonei: a case report with an unusual clinical presentation.

Authors:  Zisis Touloumis; George Galyfos; Nikolaos Kavouras; Michalis Menis; Laurant Lavant
Journal:  Case Rep Oncol Med       Date:  2013-11-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.